A detailed history of Golden State Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 3,519 shares of BMY stock, worth $207,796. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,519
Previous 2,942 19.61%
Holding current value
$207,796
Previous $215,000 92477.67%
% of portfolio
0.03%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$51.92 - $59.94 $29,957 - $34,585
577 Added 19.61%
3,519 $199 Million
Q1 2022

May 19, 2022

SELL
$61.48 - $73.72 $32,522 - $38,997
-529 Reduced 15.24%
2,942 $215,000
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $31,047 - $37,228
-505 Reduced 12.7%
3,471 $219,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $213,232 - $248,579
3,976 New
3,976 $248,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $188,219 - $220,475
-3,181 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $17,953 - $19,551
-290 Reduced 8.35%
3,181 $213,000
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $109,719 - $123,402
-1,849 Reduced 34.76%
3,471 $219,000
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $70,442 - $79,824
1,220 Added 29.76%
5,320 $330,000
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $235,463 - $260,924
4,100 New
4,100 $247,000
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $179,864 - $210,279
-3,281 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $152,238 - $221,237
3,281 New
3,281 $183,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Golden State Wealth Management, LLC Portfolio

Follow Golden State Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Wealth Management, LLC with notifications on news.